Connect with us

Hi, what are you looking for?

Investing

R3D Secures Additional Funding

R3D Resources Limited (ASX: R3D) (the Company) (renamed Tartana Minerals Limited) is pleased to note that it has received a commitment from an Investor to participate in a $480,000 Convertible Note in R3D and provides an update on the Rights Issue currently being conducted by the Company.

Key Points:

$480,000 received from an investor introduced to the Company by directors Dr Alistair Lewis and Dr Stephen Bartrop in a cash advance, pending issue of a Convertible Note on terms to be finalised;Rights Issue raising up to $1.5 million at $0.05 per share to be extended by a further week, to 27 March 2024; andConfidential, incomplete discussions are underway with prospective underwriters for the Rights Issue – including a related party underwriter.

Convertible Note

The Company has secured a commitment from an Investor to participate in a Convertible Note raising totalling $480,000, converting at $0.05 per Share. The $480,000 has been advanced to the Company prior to finalising terms of the Convertible Note and execution of formal documentation. In the time between the receipt of the funds and the issue of the Convertible Note, the Company has agreed to treat the funds as an unsecured loan on ordinary commercial terms. Further details of the terms of the advance, and the Convertible Note is set out in Annexure A.

The Investor was introduced to the Company by directors Alistair Lewis and Stephen Bartrop, although the Investor is not a party related to the Company or either director.

Rights Issue

The Rights Issue is a 1 for 5 pro rata entitlement offer of New Shares in the Company at an issue price of $0.05 per New Share, as well as 1 attaching Option exercisable at $0.10 expiring 31 December 2025 for each 2 New Shares subscribed for (the Rights Issue), which opened on 24 November 2023.

Eligible Shareholders can review the Rights Issue Prospectus and apply from the Company’s website: www.r3dresources.com.au or at www.computersharecas.com.au/r3dnrri.

The Company intends to further extend the Rights Issue offer open period until 27 March 2024 citing the impending completion of negotiations with certain parties who will commit to an underwriting of the Rights Issue. One of the parties with whom discussions are ongoing is a related party of the Company, being an entity controlled by Dr Stephen Bartrop. Any such underwriting would be on arms’ length terms.

Click here for the full ASX Release

This post appeared first on investingnews.com
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    An Italian holiday may be a priceless experience for those who have enjoyed all this country has to offer. But the summer of 2023...

    Editor's Pick

    Premature babies at Gaza’s largest hospital are being wrapped in foil and placed next to hot water in a desperate bid to keep them...

    Editor's Pick

    A 7.5 magnitude earthquake struck western Japan on Monday afternoon, triggering tsunami alerts as far away as eastern Russia and prompting a warning for...

    Editor's Pick

    Tensions are boiling over in Israel as frustrated families of hostages demand answers from the government about the fate of their loved ones and...

    Disclaimer: findandfunds.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2023 findandfunds.com